Advanced Energy pulls out of XP Power pursuit June 18, 2024 US semiconductor firm Advanced Energy is no longer pursuing a deal for XP Power after it had three informal approaches rejected by the Singapore competitor.
Nvidia boss Jensen Huang declares new industrial revolution as AI stock keeps gaining June 13, 2024 Nvidia recently reported $26bn in revenue for the first quarter of fiscal year 2025, a 262 per cent increase from the previous year.
Apple overtakes Microsoft as world’s most valuable company June 12, 2024 Apple shares rose nearly five per cent to a new record high of $218.02 per share on Wednesday, making it more valuable than Microsoft.
Buzzfeed urged to go right wing after Ramaswamy takes stake May 28, 2024 Activist investor Vivek Ramaswamy has demanded Buzzfeed feature more right-wing voices and cut jobs after he bought a near eight per cent stake in the firm.
Biffa owner to buy renewable energy giant Atlantica for £2bn May 28, 2024 Atlantica Sustainable Infrastructure is to go private after accepting an offer from a private equity firm which values it at $2.5bn (£2bn).
Donald Trump’s Truth Social craters to $300m loss amid market manipulation claims May 21, 2024 Trump Media and Technology Group's primary asset Truth Social generated just $770,500 in sales over the quarter.
FTSE 100 trounces US and Europe since start of interest rate hikes May 16, 2024 The FTSE 100 has been a winning index in the higher interest rate world.
Arrival: The full story of how a £9bn electric vehicle firm collapsed into administration April 11, 2024 The full story of how the UK businesses of electric vehicle company Arrival collapsed into administration owing more than £1bn has been revealed for the first time.
Truth Social owner soars after float sets up £3.6bn windfall for Donald Trump March 27, 2024 Donald Trump could be in line for a £3.6bn windfall after his social media company's share price soared on its debut on New York's Nasdaq stock exchange.
Redx Pharma signs $880m deal with Nasdaq-listed Jazz Pharmaceuticals February 7, 2024 Redx Pharma has signed a deal worth $880m with a Nasdaq-listed US counterpart.